BioMarin Pharmaceutical, Inc. (BMRN)
54.68
-1.37
(-2.44%)
USD |
NASDAQ |
Oct 16, 16:00
54.68
0.00 (0.00%)
After-Hours: 20:00
BioMarin Pharmaceutical Cash and Short Term Investments (Quarterly) : 874.00M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 874.00M |
| March 31, 2026 | 2.222B |
| December 31, 2025 | 1.561B |
| September 30, 2025 | 1.478B |
| June 30, 2025 | 1.432B |
| March 31, 2025 | 1.272B |
| December 31, 2024 | 1.138B |
| September 30, 2024 | 930.44M |
| June 30, 2024 | 1.224B |
| March 31, 2024 | 1.047B |
| December 31, 2023 | 1.074B |
| September 30, 2023 | 1.126B |
| June 30, 2023 | 1.171B |
| March 31, 2023 | 1.152B |
| December 31, 2022 | 1.292B |
| September 30, 2022 | 1.274B |
| June 30, 2022 | 1.110B |
| March 31, 2022 | 1.056B |
| December 31, 2021 | 1.014B |
| September 30, 2021 | 1.079B |
| June 30, 2021 | 1.123B |
| March 31, 2021 | 1.087B |
| December 31, 2020 | 1.065B |
| September 30, 2020 | 1.506B |
| June 30, 2020 | 1.380B |
| Date | Value |
|---|---|
| March 31, 2020 | 858.40M |
| December 31, 2019 | 753.81M |
| September 30, 2019 | 720.79M |
| June 30, 2019 | 731.10M |
| March 31, 2019 | 894.85M |
| December 31, 2018 | 1.084B |
| September 30, 2018 | 1.443B |
| June 30, 2018 | 1.363B |
| March 31, 2018 | 1.383B |
| December 31, 2017 | 1.396B |
| September 30, 2017 | 1.257B |
| June 30, 2017 | 737.10M |
| March 31, 2017 | 682.87M |
| December 31, 2016 | 789.68M |
| September 30, 2016 | 1.035B |
| June 30, 2016 | 503.29M |
| March 31, 2016 | 456.85M |
| December 31, 2015 | 599.97M |
| September 30, 2015 | 642.07M |
| June 30, 2015 | 688.71M |
| March 31, 2015 | 1.016B |
| December 31, 2014 | 945.19M |
| September 30, 2014 | 666.37M |
| June 30, 2014 | 836.62M |
| March 31, 2014 | 887.48M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Ascendis Pharma A/S | 928.66M |
| ACADIA Pharmaceuticals, Inc. | 956.47M |
| Alnylam Pharmaceuticals, Inc. | 3.308B |
| Anika Therapeutics, Inc. | 38.41M |
| Cytokinetics, Inc. | 1.169B |